Credit Industriel ET Commercial Invests $3.26 Million in STAAR Surgical Company $STAA

Credit Industriel ET Commercial bought a new position in shares of STAAR Surgical Company (NASDAQ:STAA) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 121,258 shares of the medical instruments supplier’s stock, valued at approximately $3,258,000. Credit Industriel ET Commercial owned approximately 0.25% of STAAR Surgical as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Amalgamated Bank grew its stake in STAAR Surgical by 3.6% during the third quarter. Amalgamated Bank now owns 14,609 shares of the medical instruments supplier’s stock worth $393,000 after buying an additional 514 shares during the last quarter. CWM LLC boosted its holdings in shares of STAAR Surgical by 74.1% in the 2nd quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 665 shares in the last quarter. GAMMA Investing LLC grew its position in STAAR Surgical by 61.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier’s stock worth $50,000 after acquiring an additional 706 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in STAAR Surgical by 7.8% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,711 shares of the medical instruments supplier’s stock valued at $213,000 after purchasing an additional 923 shares in the last quarter. Finally, Franklin Resources Inc. raised its position in STAAR Surgical by 3.0% in the 2nd quarter. Franklin Resources Inc. now owns 35,175 shares of the medical instruments supplier’s stock valued at $590,000 after purchasing an additional 1,012 shares during the last quarter. 96.70% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Needham & Company LLC restated a “hold” rating on shares of STAAR Surgical in a report on Tuesday, January 6th. Wedbush initiated coverage on shares of STAAR Surgical in a research report on Tuesday, February 3rd. They set a “neutral” rating and a $26.00 price target on the stock. Stifel Nicolaus lowered their price objective on shares of STAAR Surgical from $28.00 to $19.00 and set a “hold” rating for the company in a research report on Monday, February 9th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of STAAR Surgical in a research note on Thursday, January 22nd. Finally, BTIG Research reiterated a “neutral” rating on shares of STAAR Surgical in a research report on Tuesday, January 6th. One equities research analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus target price of $20.91.

STAAR Surgical Price Performance

STAA opened at $16.10 on Monday. The firm has a 50 day simple moving average of $21.40 and a 200 day simple moving average of $24.76. STAAR Surgical Company has a fifty-two week low of $14.69 and a fifty-two week high of $30.81. The company has a market cap of $800.81 million, a price-to-earnings ratio of -8.26 and a beta of 1.06.

Insider Activity at STAAR Surgical

In related news, major shareholder Broadwood Partners, L.P. bought 27,485 shares of the business’s stock in a transaction on Friday, January 9th. The shares were purchased at an average price of $22.05 per share, with a total value of $606,044.25. Following the completion of the purchase, the insider owned 15,453,629 shares of the company’s stock, valued at $340,752,519.45. This represents a 0.18% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders acquired 1,934,138 shares of company stock worth $50,485,791 over the last ninety days. 0.59% of the stock is owned by insiders.

STAAR Surgical Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.